1981
DOI: 10.1016/s0015-0282(16)45440-3
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of progesterone and R5020 binding in endometrium, ovary, pituitary, and hypothalamus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1986
1986
2021
2021

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…T47D cells were treated with control, R5020 (10 nM), irilone (10 μM), and R5020 (10 nM) plus irilone (10 μM) for 60 min. R5020 is a synthetic progestin agonist that binds to PR with high binding affinity, behaves like progesterone in the genomic signaling pathway, and is a ligand that is typically used in the literature to understand PR biology . R5020 differs from progesterone in that R5020 does not bind to membrane progesterone receptors (mPR), and therefore does not elicit the rapid nongenomic effects of progesterone .…”
Section: Resultsmentioning
confidence: 99%
“…T47D cells were treated with control, R5020 (10 nM), irilone (10 μM), and R5020 (10 nM) plus irilone (10 μM) for 60 min. R5020 is a synthetic progestin agonist that binds to PR with high binding affinity, behaves like progesterone in the genomic signaling pathway, and is a ligand that is typically used in the literature to understand PR biology . R5020 differs from progesterone in that R5020 does not bind to membrane progesterone receptors (mPR), and therefore does not elicit the rapid nongenomic effects of progesterone .…”
Section: Resultsmentioning
confidence: 99%